Journal of Comprehensive Pediatrics

Published by: Kowsar

Lifestyle Intervention and Vitamin E Therapy in Obese Children with Nonalcoholic Fatty Liver Disease

Robabeh Ghergherehchi 1 , * , Nazanin Hazhir 1 and Manizheh Mostafa Gharehbaghi 1
Authors Information
1 Pediatric Endocrine Department, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Journal of Comprehensive Pediatrics: October 25, 2012, 4 (1); 62-5
  • Published Online: October 25, 2012
  • Article Type: Research Article
  • Received: July 5, 2012
  • Revised: September 29, 2012
  • Accepted: October 3, 2012
  • DOI: 10.17795/compreped-6249

To Cite: Ghergherehchi R, Hazhir N, Mostafa Gharehbaghi M. Lifestyle Intervention and Vitamin E Therapy in Obese Children with Nonalcoholic Fatty Liver Disease, J Compr Ped. 2012 ; 4(1):62-5. doi: 10.17795/compreped-6249.

Abstract
Copyright © 2012, Iranian Society of Pediatrics. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezynska-Kurtycz J, Milkiewicz P. [Non-alcoholic fatty liver disease--new view]. Pol Merkur Lekarski. 2008; 24(144): 568-71
  • 2. Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics. 2005; 115(5)-5[DOI][PubMed]
  • 3. Yiu D, Leung N. Epidemiological study: nonalcoholic fatty liver disease in Hong Kong Chinese. 2004;
  • 4. Tarantino G, Saldalamacchia G, Conca P, Arena A. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol. 2007; 22(3): 293-303[DOI][PubMed]
  • 5. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346(16): 1221-31[DOI][PubMed]
  • 6. Rafeey M, Mortazavi F, Mogaddasi N, Robabeh G, Ghaffari S, Hasani A. Fatty liver in children. Ther Clin Risk Manag. 2009; 5(2): 371-4[DOI][PubMed]
  • 7. Kinugasa A, Tsunamoto K, Furukawa N, Sawada T, Kusunoki T, Shimada N. Fatty liver and its fibrous changes found in simple obesity of children. J Ped Gastroenterol Nutr. 1984; 3(3): 408-14[DOI][PubMed]
  • 8. Reinehr T, Schmidt C, Toschke AM, Andler W. Lifestyle intervention in obese children with non-alcoholic fatty liver disease: 2-year follow-up study. Arch Dis Child. 2009; 94(6): 437-42[DOI][PubMed]
  • 9. Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J hepat. 1997; 27(1): 103-7[DOI]
  • 10. Uygun A, Kadayifci A, Isik AT, Ozgurtas T, Deveci S, Tuzun A, et al. Metformin in the treatment of patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2004; 19(5): 537-44[DOI][PubMed]
  • 11. Bugianesi E, Gentilcore E, Manini R, Natale S, Vanni E, Villanova N. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol. 2005; 100(5): 1082-90[DOI][PubMed]
  • 12. Lindor KD, Kowdley KV, Heathcote EJ, Harrison ME, Jorgensen R, Angulo P, et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial. Hepatology. 2004; 39(3): 770-8
  • 13. Palmer M, Schaffner F. Effect of weight reduction on hepatic abnormalities in overweight patients. Gastroenterology. 1990; 99(5): 1408-13
  • 14. Manning PJ, Sutherland WH, Walker RJ, Williams SM, De Jong SA, Ryalls AR. Effect of high-dose vitamin E on insulin resistance and associated parameters in overweight subjects. Diabetes Care. 2004; 27(9): 2166-71
  • 15. Hasegawa T, Yoneda M, Nakamura K, Makino I, Terano A. Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther. 2001; 15(10): 1667-72
  • 16. Nobili V, Manco M, Devito R, Ciampalini P, Piemonte F, Marcellini M. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2006; 24(11-12): 1553-61
  • 17. Vajro P, Franzese A, Valerio G, Iannucci MP, Aragione N. Lack of efficacy of ursodeoxycholic acid for the treatment of liver abnormalities in obese children. J Pediatr. 2000; 136(6): 739-43[DOI]
  • 18. Lavine JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr. 2000; 136(6): 734-8[DOI][PubMed]
  • 19. Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology. 2003; 38(2): 413-9[DOI][PubMed]
  • 20. Wang CL, Liang L, Fu JF, Zou CC, Hong F, Xue JZ, et al. Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children. World J Gastroenterol. 2008; 14(10): 1598-602[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments